Project ETAL3-ASAP

Basic data

Title:
ETAL3-ASAP
Duration:
14/07/2015 to 31/12/2020
Abstract / short description:
Evaluation of the impact of remission induction chemotherapy prior to allogeneic stem cell transplantation in relapsed and poor- response patients with AML (ETAL3-ASAP)

Involved staff

Managers

Department of Internal Medicine
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Other Faculty of Medicine facilities
Faculty of Medicine
University of Tübingen

Funders

Tübingen, Baden-Württemberg, Germany
Help

will be deleted permanently. This cannot be undone.